Navigation Links
Genetic Engineering and Biotechnology News (GEN) Presents Exclusive Podcast with Robert Langer, Ph.D. on New Polymeric Drug Delivery Systems
Date:4/9/2008

NEW ROCHELLE, N.Y., April 9, 2008 /PRNewswire/ -- Genetic Engineering and Biotechnology News (GEN), http://www.genengnews.com will present a podcast with Robert Langer, Ph.D., on New Polymeric Drug Delivery Systems, on Thursday, April 10, 2008, 4 p.m. EDT

Dr. Langer is institute professor, chemical and biomedical engineering, Massachusetts Institute of Technology. "Robert Langer is the foremost pioneer and innovator in modern drug delivery," says John Sterling, Editor-in-Chief of Genetic Engineering and Biotechnology News. "Dr. Langer and his team continue to advance research and development on novel biomaterials and tissue- engineered products. They are constantly pushing the technology envelope for new ways to deliver biodrugs and pharmaceuticals."

This podcast is imperative for researchers and biotechnology, pharmaceutical and medical device executives whose companies are engaged in drug discovery and development, as well as market makers, analysts, and investors who must be knowledgeable about the challenges and directions in therapeutic delivery. The podcast will be featured until April 17th on http://www.genengnews.com and then archived on the site.

Dr. Langer has more than 600 issued or pending patents. The patents have been licensed or sublicensed to over 200 pharmaceutical, chemical, biotechnology, and medical device companies, many of which were launched on the basis of these patent licenses. He served as a member of the FDA's science advisory board from 1995-2002 and as chairman from Chairman from 1999-2002.

In this exclusive podcast, Dr. Langer discusses the drug-delivery projects currently drawing his team's attention in the laboratory. He addresses the application of nanotechnology to the creation of new drug delivery systems. In addition, he specifically looks at what gene therapy-technology must overcome before it can become a viable delivery system. Dr. Langer also will present an update on his group's work in the field of tissue engineering, including the recent creation of a Gecko-Inspired Bandage.

Genetic Engineering and Biotechnology News (GEN) is published in print 21 times a year by Mary Ann Liebert, Inc. (http://www.liebertpub.com) GEN's website, http://www.genengnews.com presents and updates news and financial information 24/7.

Contact: John Sterling, Editor-in-Chief, Genetic Engineering and Biotechnology News, jsterling@genengnews.com, Ph: 914.740-2196; Cell: 646.234-5118


'/>"/>
SOURCE Genetic Engineering and Biotechnology News
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. U.S. Preventive Medicine and deCODE Genetics Sign Letter of Intent to Expand Personalized Medicine Platform
2. Genetic Engineering & Biotechnology News reports on cancer biomarkers
3. deCODE genetics to Webcast Presentation at 15th Annual Future Leaders in the Biotech Industry Conference
4. Interleukin Genetics Announces Conference Call and Webcast to Discuss Fourth Quarter and Year End 2007 Business Results
5. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
6. Interleukin Genetics Retains Top Life Science Communications Firms
7. On the trail of rogue genetically modified pathogens
8. deCODE genetics to Webcast Presentation at Lehman Brothers Eleventh Annual Global Healthcare Conference
9. deCODE Genetics Announces Full-year 2007 Financial Results
10. Genetic manipulation might model cystic fibrosis
11. NIOXIN(R) Delivers the Future to Scalp and Hair Care, Introduces the First Genetic Test to Determine the Likelihood of Hair Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- Houston Methodist Willowbrook Hospital has signed a ... serve as their official health care provider. As ... provide sponsorship support, athletic training services, and most ... athletes and families. "We are excited ... to bring Houston Methodist quality services and programs ...
(Date:6/23/2016)...   EpiBiome , a precision microbiome engineering company, ... financing from Silicon Valley Bank (SVB). The financing will ... its drug development efforts, as well as purchase additional ... has been an incredible strategic partner to us – ... would provide," said Dr. Aeron Tynes Hammack , ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free ... and will showcase its product’s latest features from June 26 to June 30, ... poster on Disrupting Clinical Trials in The Cloud during the conference. DIA ...
Breaking Biology Technology:
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour ... from the Q1 wave of its quarterly wearables survey. ... receptivity to a program where they would receive discounts ... company. "We were surprised to see that ... LaColla , CEO of Troubadour Research, "primarily because there ...
(Date:4/26/2016)... LONDON , April 26, 2016 /PRNewswire/ ... Systems, a product subsidiary of Infosys (NYSE: ... partnership to integrate the Onegini mobile security platform ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration ... security to access and transact across channels. Using ...
(Date:4/14/2016)... , April 14, 2016 ... Malware Detection, today announced the appointment of Eyal ... new role. Goldwerger,s leadership appointment comes at ... heels of the deployment of its platform at several ... biometric technology, which discerns unique cognitive and physiological factors, ...
Breaking Biology News(10 mins):